Evidence map›Paper›PMID 37334166›Full record

ArticleNeuro-oncology advances

Glioblastoma extracellular vesicles influence glial cell hyaluronic acid deposition to promote invasiveness.

Dominik Koessinger, David Novo, Anna Koessinger, America Campos, Jasmine Peters, Louise Dutton, Peggy Paschke, Désirée Zerbst, Madeleine Moore, Louise Mitchell and 6 more

Open access · goldAbstract read
In one paragraph

Article in Neuro-oncology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Dominik KoessingerCancer Research UK Beatson Institute, Glasgow, UK.
David NovoCancer Research UK Beatson Institute, Glasgow, UK.
Anna KoessingerCancer Research UK Beatson Institute, Glasgow, UK.
America CamposCancer Research UK Beatson Institute, Glasgow, UK.
Jasmine PetersCancer Research UK Beatson Institute, Glasgow, UK.
Louise DuttonSchool of Cancer Sciences, University of Glasgow, Glasgow, UK.
Peggy PaschkeCancer Research UK Beatson Institute, Glasgow, UK.
Désirée ZerbstCancer Research UK Beatson Institute, Glasgow, UK.
Madeleine MooreCancer Research UK Beatson Institute, Glasgow, UK.
Louise MitchellCancer Research UK Beatson Institute, Glasgow, UK.
Matthew NeilsonCancer Research UK Beatson Institute, Glasgow, UK.
Katrina StevensonSchool of Cancer Sciences, University of Glasgow, Glasgow, UK.
Anthony ChalmersSchool of Cancer Sciences, University of Glasgow, Glasgow, UK.
Stephen TaitCancer Research UK Beatson Institute, Glasgow, UK.
Joanna BirchSchool of Cancer Sciences, University of Glasgow, Glasgow, UK.
Jim NormanCancer Research UK Beatson Institute, Glasgow, UK.ORCID https://orcid.org/0000-0002-0098-3014
Cancer Research UK Scotland Institute · GBUniversity of Glasgow · GBUniversity Medical Center Freiburg · DE

Funding

Cancer Research UK 28291Cancer Research UK 28803Medical Research Council MR/R009473/1
6 · The paper itself

Abstract

Background: Infiltration of glioblastoma (GBM) throughout the brain leads to its inevitable recurrence following standard-of-care treatments, such as surgical resection, chemo-, and radiotherapy. A deeper understanding of the mechanisms invoked by GBM to infiltrate the brain is needed to develop approaches to contain the disease and reduce recurrence. The aim of this study was to discover mechanisms through which extracellular vesicles (EVs) released by GBM influence the brain microenvironment to facilitate infiltration, and to determine how altered extracellular matrix (ECM) deposition by glial cells might contribute to this. Methods: CRISPR was used to delete genes, previously established to drive carcinoma invasiveness and EV production, from patient-derived primary and GBM cell lines. We purified and characterized EVs released by these cells, assessed their capacity to foster pro-migratory microenvironments in mouse brain slices, and evaluated the contribution made by astrocyte-derived ECM to this. Finally, we determined how CRISPR-mediated deletion of genes, which we had found to control EV-mediated communication between GBM cells and astrocytes, influenced GBM infiltration when orthotopically injected into CD1-nude mice. Results: GBM cells expressing a p53 mutant (p53 Conclusions: This work describes several key components of an EV-mediated mechanism though which GBM cells educate astrocytes to support infiltration of the surrounding healthy brain tissue.

Indexed as

astrocytesextracellular matrixextracellular vesiclesGBMinvasion

Identifiers

PMID37334166
PMCPMC10276538
OpenAlexW4378575003

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.